Concepts (86)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Skin Neoplasms | 5 | 2023 | 118 | 0.990 |
Why?
|
| Anilides | 1 | 2015 | 19 | 0.490 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2015 | 12 | 0.490 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2015 | 8 | 0.490 |
Why?
|
| Surgery, Plastic | 2 | 2012 | 19 | 0.490 |
Why?
|
| Pyridines | 1 | 2015 | 102 | 0.460 |
Why?
|
| Internship and Residency | 2 | 2020 | 228 | 0.460 |
Why?
|
| Earthquakes | 1 | 2012 | 5 | 0.410 |
Why?
|
| Disasters | 1 | 2012 | 15 | 0.400 |
Why?
|
| Antineoplastic Agents | 1 | 2015 | 658 | 0.330 |
Why?
|
| Reconstructive Surgical Procedures | 3 | 2020 | 72 | 0.290 |
Why?
|
| Sigmodontinae | 1 | 2006 | 1 | 0.260 |
Why?
|
| Industrial Waste | 1 | 2006 | 7 | 0.260 |
Why?
|
| Melanoma | 2 | 2017 | 128 | 0.250 |
Why?
|
| DNA Damage | 1 | 2006 | 149 | 0.240 |
Why?
|
| Buttocks | 1 | 2020 | 6 | 0.180 |
Why?
|
| Patient Positioning | 1 | 2020 | 22 | 0.180 |
Why?
|
| Gracilis Muscle | 1 | 2020 | 1 | 0.170 |
Why?
|
| Surgical Wound | 1 | 2020 | 2 | 0.170 |
Why?
|
| Infection Control | 1 | 2020 | 31 | 0.170 |
Why?
|
| Myocutaneous Flap | 1 | 2020 | 3 | 0.170 |
Why?
|
| Schools, Medical | 1 | 2020 | 45 | 0.170 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 47 | 0.160 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 51 | 0.160 |
Why?
|
| Students, Medical | 1 | 2020 | 95 | 0.160 |
Why?
|
| Pandemics | 1 | 2020 | 176 | 0.150 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2020 | 466 | 0.140 |
Why?
|
| Stevens-Johnson Syndrome | 1 | 2017 | 3 | 0.140 |
Why?
|
| Carcinoma in Situ | 1 | 2017 | 44 | 0.140 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2017 | 37 | 0.140 |
Why?
|
| Retrospective Studies | 3 | 2023 | 2454 | 0.140 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 84 | 0.130 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 123 | 0.130 |
Why?
|
| Muscle, Skeletal | 1 | 2020 | 622 | 0.130 |
Why?
|
| Aged | 4 | 2023 | 5222 | 0.130 |
Why?
|
| Middle Aged | 5 | 2020 | 6900 | 0.130 |
Why?
|
| Hemangiosarcoma | 1 | 2015 | 2 | 0.130 |
Why?
|
| Hedgehog Proteins | 1 | 2015 | 33 | 0.120 |
Why?
|
| Humans | 10 | 2023 | 27121 | 0.120 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2015 | 109 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2017 | 318 | 0.120 |
Why?
|
| Neoadjuvant Therapy | 1 | 2015 | 69 | 0.120 |
Why?
|
| Skin | 1 | 2015 | 140 | 0.110 |
Why?
|
| Male | 5 | 2023 | 13022 | 0.110 |
Why?
|
| Haiti | 1 | 2012 | 3 | 0.100 |
Why?
|
| International Cooperation | 1 | 2012 | 18 | 0.100 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 988 | 0.100 |
Why?
|
| Florida | 1 | 2012 | 54 | 0.100 |
Why?
|
| Treatment Outcome | 2 | 2017 | 2283 | 0.100 |
Why?
|
| Physician-Patient Relations | 1 | 2012 | 112 | 0.090 |
Why?
|
| Margins of Excision | 2 | 2023 | 9 | 0.090 |
Why?
|
| Wounds and Injuries | 1 | 2012 | 166 | 0.090 |
Why?
|
| Substance-Related Disorders | 1 | 2011 | 175 | 0.070 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2023 | 312 | 0.070 |
Why?
|
| Female | 5 | 2020 | 14636 | 0.070 |
Why?
|
| Mining | 1 | 2006 | 3 | 0.070 |
Why?
|
| Lead | 1 | 2006 | 8 | 0.070 |
Why?
|
| G1 Phase | 1 | 2006 | 15 | 0.070 |
Why?
|
| Cadmium | 1 | 2006 | 14 | 0.070 |
Why?
|
| Soil Pollutants | 1 | 2006 | 16 | 0.070 |
Why?
|
| Coal | 1 | 2006 | 11 | 0.070 |
Why?
|
| Spleen | 1 | 2006 | 109 | 0.060 |
Why?
|
| Zinc | 1 | 2006 | 63 | 0.060 |
Why?
|
| Flow Cytometry | 1 | 2006 | 285 | 0.060 |
Why?
|
| Prone Position | 1 | 2020 | 5 | 0.040 |
Why?
|
| Personnel Selection | 1 | 2020 | 7 | 0.040 |
Why?
|
| Perineum | 1 | 2020 | 14 | 0.040 |
Why?
|
| Pelvis | 1 | 2020 | 37 | 0.040 |
Why?
|
| Betacoronavirus | 1 | 2020 | 37 | 0.040 |
Why?
|
| Feasibility Studies | 1 | 2020 | 191 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2020 | 1219 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 66 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2017 | 180 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 7492 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 930 | 0.030 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2017 | 92 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 150 | 0.030 |
Why?
|
| Young Adult | 1 | 2020 | 2626 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 1940 | 0.020 |
Why?
|
| Animals | 1 | 2006 | 10085 | 0.020 |
Why?
|
| N-Methyl-3,4-methylenedioxyamphetamine | 1 | 2011 | 2 | 0.020 |
Why?
|
| Marijuana Abuse | 1 | 2011 | 14 | 0.020 |
Why?
|
| Benzodiazepines | 1 | 2011 | 10 | 0.020 |
Why?
|
| Amphetamines | 1 | 2011 | 11 | 0.020 |
Why?
|
| Cocaine-Related Disorders | 1 | 2011 | 17 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2011 | 104 | 0.020 |
Why?
|